Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2019 Earnings Call Transcript

Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2019 Earnings Call Transcript

Welcome and thank you for joining the Fresenius Medical Care Earnings Call on the Fourth Quarter and Full-Year 2019 Results.. We would like to welcome all of you to the Fresenius Medical Care earnings call for the fourth quarter and full-year 2019.. With us today is Rice Powell, our CEO and Chairman of the Management Board.. Rice will give you some more color around the strategy and the recent business development, and go through some of the major topics of the quarter.. We did compensate all of this year, where we were focused on investments in home dialysis and our growth markets.. We had a very strong performance in our underlying business throughout the year, as well as our cost and efficiency initiatives ran quite well over the course of 2019.. You see the growth categories across clinics, patients and treatments.. Moving to Slide 5, we just want to come back and ground you that the organic growth drivers in this business remain intact.. We expect 6% growth rate to continue over the next years, and we still believe in 2025, we will be just shy of 5 million patients on dialysis.. Moving to Slide 6, a little more information